Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)-Reference-Cited by-同舟云学术

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)

Published:2004-06 Issue:4 Volume:6 Page:467-475
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Komajda Michel¹,Lutiger Beatrix²,Madeira Hugo³,Thygesen Kristian⁴,Bobbio Marco⁵,Hildebrandt Per⁶,Jaarsma Wybren⁷,Riegger Günter⁸,Rydén Lars⁹,Scherhag Armin²,Soler-Soler Jordi¹⁰,Remme Willem J.¹¹,

Affiliation:

1. Institut de Cardiologie, Centre Hospitalier GH Pitié-Salpêtrière; 47-83 Bld de l'Hôpital 75013 Paris Cedex 13 France

2. F. Hoffmann-La Roche; Basel Switzerland

3. Hospital de Santa Maria; Lisboa Portugal

4. Aarhus University Hospital; Aarhus Denmark

5. Hospital Le Molinette; Torino Italy

6. Frederiksberg Hospital; Frederiksberg Denmark

7. St. Antonius Hospital; Nieuwegein The Netherlands

8. University of Regensburg; Regensburg Germany

9. Karolinska Hospital; Stockholm Sweden

10. University Hospital Vall d'Hebron Barcelona; Spain

11. Sticares Foundation; Rhoon The Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Task force for the diagnosis and treatment of chronic heart failure, European society of cardiology guidelines for the diagnosis and treatment of chronic heart failure;Remme;Eur Heart J,2001

2. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult;Hunt;Circulation,2001

3. European survey of primary care physician perceptions on heart failure diagnosis and management (EURO-HF);Hobbs;Eur Heart J,2000

4. The Euro heart failure survey programme: a survey on the quality of care among patients with heart failure in Europe: treatment;Komajda;Eur Heart J,2003

5. Replacement of angiotensin converting enzyme inhibition by carvedilol results in long-term reversed left ventricular remodeling in mild heart failure and is well tolerated: results of the CARMEN (Carvedilol ACE-inhibitor remodeling in mild heart failure evaluation) Study;Remme;J Am Coll Cardiol,2003

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial;The Lancet Oncology;2024-02

2. Impacto de la presión arterial en el tratamiento y pronóstico de los pacientes tratados con sacubitrilo/valsartán;REC: CardioClinics;2022-04

3. Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose?;European Journal of Heart Failure;2022-02-22

4. Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia;VASC HEALTH RISK MAN;2022

5. Revisiting the clinical evidence of heart rate target in patients with heart failure treated with beta-blockers;The Anatolian Journal of Cardiology;2021-11-05